PBT down 33% on a 1.2% revenue dip as inventories balloon 37%

What changed

Revenue eased 1.2% to $494.9m, but profit before tax fell 33.3% to $13.9m and NPAT dropped 35.2% to $9.3m. The effective tax rate was essentially unchanged at 28.3% (HY23: 28.1%), so PBT and NPAT declines move together — this is an operating margin result, not a tax-line artefact. The interim dividend was held at 15.0 cps.

On the balance sheet, inventories rose 36.8% to $269.9m, total assets grew 18.7% to $625.5m, and total liabilities jumped 41.2% to $316.9m. Gross borrowings rose to $115.3m from $105.8m, cash fell to $12.8m from $16.1m, and net debt increased to $102.5m from $89.7m. Operating cash flow was negative $48.4m, a marginal improvement on the negative $50.7m in HY23 but still a large half-year outflow.

What matters

• Margin compression, not a revenue problem. With revenue down only 1.2% but PBT down 33.3%, the decisive issue is operating margin. Management has framed HY23 as an exceptionally strong comparator, which is consistent with normalisation rather than structural damage, but the release does not quantify what is cyclical versus durable.
• Inventory build is the dominant balance-sheet event. A $72.6m (36.8%) lift in inventories is funded through a $9.4m rise in gross borrowings and the drawdown in cash. This is the mechanism behind the leverage shift from $89.7m to $102.5m of net debt.
• Payout ratio has stepped up sharply. Holding the interim at 15 cps against a lower NPAT pushes the implied payout ratio versus interim NPAT to ~53.0% from ~34.3% a year ago. ROE has softened to ~3.0% (half-year) from ~4.7%.

Expectations

No quantified guidance or forward-work figure was disclosed; management referenced prior guidance issued 18 January 2024 and characterised HY23 as a very strong base. FY23 was second-half weighted — HY23 contributed only 43.1% of full-year NPAT — so a simple doubling of HY24 earnings is not the right mental model.

HY24 revenue annualises to $989.7m versus FY23's $1b, i.e. approximately flat at the top line. Replicating FY23 NPAT of $33.2m would, however, require a materially stronger second half than the $18.9m implied H2 contribution in FY23, which the release does not support with any specific evidence. What this release does support is that the top line is holding and that margin, not volume, is the swing factor.

Quality of result

The result is genuine in the sense that tax did not flatter or penalise it and there are no disclosed one-offs. However, the release uses a "trading profit" / "net trading profit" non-GAAP label alongside IFRS NPAT without a published reconciliation of adjustments, which limits the ability to bridge underlying to statutory cleanly.

Cash conversion is poor in absolute terms — a $48.4m operating outflow against $9.3m NPAT — but this is consistent with the prior-year shape (negative $50.7m against $14.3m) and with the typical working-capital seasonality of a vehicle distributor carrying floorplan-funded stock. The more notable quality signal is the $72.6m inventory lift: if underlying demand is softening into a period of rising stock, gross margin risk increases into H2. Capex, trade debtors and payables were not disclosed, so free cash flow cannot be derived.

Unresolved

• What drove the margin compression specifically — vehicle gross margin normalisation, parts/service mix, cost inflation, or a combination — and how much is cyclical versus structural?
• Is the $269.9m inventory balance aligned to committed orders, or does it carry markdown risk if demand softens further?
• What is the reconciliation between "trading profit" and statutory NPAT, and are there underlying adjustments investors should be aware of?
• What is the dealership-level forward order book, and how does management view H2 relative to FY23's stronger second half?

This briefing cannot assess vehicle-segment demand conditions, floorplan finance terms, or dealership-level operating performance, none of which are quantified in the supplied excerpts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.